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Abstract
Background: Epidemiological research reveals that the incidence of allergic diseases and that of autoimmune
diseases have been increasing in parallel, raising an interest in a potential link between the two disorders. However,
the relationship between Th2-mediated allergic disease and Th1-mediated juvenile idiopathic arthritis (JIA) remains
unclear. This population-based case-control study was aimed at investigating the development of childhood-onset
allergic diseases and the subsequent risks of JIA.
Methods: We included 329 children with JIA diagnosed between 2000 and 2008, and 1316 age- and sex-matched
controls. The odds ratios of developing JIA were calculated to determine an association with preexisting allergic
diseases.
Results: The incidence rate of JIA in Taiwan between 2000 and 2008 was 1.33 cases per 100,000 children/year
according to the International League of Associations for Rheumatology (ILAR) criteria. The children with a single
allergic disease had an increased risk of JIA, with adjusted odds ratios of developing JIA of 1.44 for allergic
conjunctivitis (95 % confidence interval [CI], 1.07–1.95), 1.50 for allergic rhinitis (1.15–1.96), and 1.44 for asthma
(1.00–2.10). The adjusted odds ratios increased with the number of concurrent allergic diseases from 1.50 (95 % CI,
1.12–2.01) for those with only one allergic disease to 1.72 (1.24–2.38) for those with at least two allergic diseases.
The adjusted odds ratios of those with at least two allergic diseases increased to 1.84 (95 % CI, 1.19–2.86) for boys
and 2.54 (1.42–4.54) for those older than 12 years. The children who made two or more medical visits for associated
allergic diseases per year had an increased risk of JIA.
Conclusion: Children with onset of allergic diseases were at increased risk of developing JIA. The increased risk was
associated with the cumulative effect of concurrent allergic diseases and frequency of seeking medical care. Further
study to investigate the role of Th2-mediated allergic diseases that contribute to the development of Th1-mediated
JIA is warranted.
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Background
Juvenile idiopathic arthritis (JIA) is a chronic inflamma-
tory disease in childhood that can lead to long-term
morbidities such as uveitis, osteoporosis, depression,
poor pain control, and even severe disability due to joint
damage [1, 2]. JIA comprises a heterogeneous group of
diseases, with chronic arthritis as a common feature [3, 4].
Although the etiology and pathogenesis of JIA are not
fully understood, individual gene susceptibility and various
environmental triggers (e.g. trauma, bacterial or viral
infection, and hormone levels) may lead to an immune
imbalance that subsequently results in articular and sys-
temic manifestations [4, 5].
The autoimmune and inflammatory features of JIA ap-
pear complex. Children with JIA were found increased
levels of activated CD4+ T-cells both in circulation and
in the synovium [6–10]. In In oligo/polyarticular JIA,
the activation of auto-reactive T-cells including Th1 and
Th17 cells induced IFN-γ and IL-17 production, respect-
ively, leading to the production of proinflammatory cyto-
kines, chemokines and mediators such as IL-1, IL-6 and
TNF-α [7–9]. On the other hand, the immunosuppres-
sive function of regulatory T-cells (Tregs) with decreased
anti-inflammatory cytokine IL-10 results in a loss of im-
mune tolerance. Imbalance between auto-reactive Th1/
Th17 and Tregs leads to the failure of T-cell tolerance to
self-antigens, which contributes to synovial inflamma-
tion and subsequent joint damage [8–10].
Despite advances in the pathophysiology of JIA, the
clear understanding of the initiating and perpetuating
factors of JIA remains limited. Recent studies have re-
vealed that the incidences of allergic and autoimmune
diseases have been increasing in parallel, making them a
serious health-care burden [11–13]. Interest in a com-
plexity link between allergic and autoimmune diseases is
increasing [13], as both involve chronic inflammatory
processes with complex etiologies, influenced by some
common genetic determinants or environmental factors.
In contrast to Th2-mediated allergic diseases, JIA is a
Th1-driven chronic inflammatory disease. However, hu-
man epidemiological studies evaluating the temporal
interaction between Th1-mediated JIA and Th2-mediated
allergic diseases are sparse. In addition, the epidemio-
logical data of JIA in Asian countries are limited.
The Taiwan National Health Insurance Research data-
base (NHIRD) provides unrestricted and universal access
to health-care facilities for Taiwan’s population. In the
present study, we used this claims dataset to investigate
the incidence and clinical presentations of JIA, and
define the influence of allergic diseases on the develop-
ment of JIA so that we could provide better insights into
the common immunological aberrancies of these condi-
tions. We hypothesized that children with atopy have in-
creased subsequent risk of JIA.
Methods
Data source
The NHIRD, maintained by the National Health Re-
search Institutes, is population-based and derived from
the claims data of the National Health Insurance pro-
gram, a mandatory-enrollment, single-payment system
created in 1995, now covering over 99 % of Taiwan’s
population [14]. This file contained all medical claims
and the information of insurant and provided a valuable
resource, a unique opportunity and sufficient sample size
to pursue the objectives addressed in this study. To en-
sure the accuracy of disease diagnosis, the National
Health Insurance Bureau of Taiwan has randomly
reviewed medical charts of 1/100 ambulatory and 1/20
inpatient claims. The high validity of the diagnostic data
from the NHIRD has been reported previously [15].
Children file (age at <18 years) was derived from the
NHI program and maintained by the National Health
Research Institutes. Children file included 50 % children
randomly selected from the Children Registry in 1996–
2008 [15, 16]. This study was an analysis of de-identified
secondary data; therefore, no informed consent was re-
quired. Although the identification information was
scrambled, this study also received approval from the In-
stitutional Review Board at China Medical University
Hospital (CMUH104-REC2-115). Diagnostic code in the
format of the International Classification of Disease, 9th
Revision, Clinical Modification (ICD-9-CM).
Subject selection
The study subjects were identified from two of sub datasets
of the NHIRD: 1) Cases were identified from the Registry
of Catastrophic Illnesses Patient Database (RCIPD), a
dataset containing health claims data for treatment of
catastrophic illness, which consists of thirty categories
of diseases that require long-term care. The insured
had major diseases such like JIA then they can apply
for a catastrophic illness certificate. In Taiwan, the
agreed-upon diagnosis and classification were the
International League of Associations for Rheumatol-
ogy (ILAR) revised classification, which refers to the
illness as JIA. To reduce the financial hardship associ-
ated with catastrophic illness, the NHI program ex-
empts beneficiaries from obligations for NHI-defined
catastrophic illnesses. Cases subjects were patients
aged less than 16 years-old, newly diagnosed with JIA
(ICD-9-CM codes 714.0-714.9.0) between 2000 and
2008 as JIA group.
Thus, the accuracy of JIA cases identified from the
RCIPD should be high; 2) Control subjects were identified
from the Longitudinal Health Insurance Database 2000
(LHID 2000), a database containing the claims data of one
million people randomly sampled from 2000 NHIRD en-
rollment file. There was no significant different in gender,
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age or health care costs between cohorts in LHID2000
and all insurance enrollees, as reported by the NHRI in
Taiwan. For each JIA, 4 JIA-free controls frequency
matched to the case on sex. We identified a total of 167
children with newly diagnosed JIA cases and 668 non-JIA
controls.
We identified the subjects who were diagnosed with
allergic conjunctivitis (ICD-9 codes: 372.05, 372.10, and
372.14), allergic rhinitis (ICD-9 code: 477), asthma
(ICD-9 codes: 493), and atopic dermatitis ((ICD-9 code:
691.8) before the diagnosis of JIA. All diagnoses of the
allergic disorders were defined as at least 3 respective
ICD-9-CM codes in any diagnosis field of inpatient
claim record or ambulatory claims. The validation of
current study corresponding to previous studies, such as
the International Study of Asthma and Allergies in
Childhood (ISAAC), has been discussed in our previous
paper [15]. The cumulative effect of disease severity was
evaluated by the number of allergic comorbidities and
frequency of seeking medical care. Both group with in-
complete information were excluded.
Statistical analysis
We used the chi-square and t-tests to analyze the demo-
graphic data between the JIA and non-JIA control
groups, and multivariate logistic regression models to
calculate the odds ratios (OR) and 95 % confidence in-
tervals (CI) after adjusting for sex for the association be-
tween pre-existing allergic diseases and JIA. All data
analyses were performed using SAS 9.1 (SAS Institute
Inc., Carey, NC), and a p value less than 0.05 was con-
sidered to be statistically significant.
Results
Table 1 shows the annual incidence rate of JIA among
Taiwanese children aged <16 years. The mean annual in-
cidence rate from 2000 to 2008 was 1.33 cases (range:
0.95–1.78 cases) per 100,000 children (Table 1). In total,
329 subjects with JIA were identified, including 161 boys
(49 %) and 168 girls (51 %; Table 2). The prevalence of
oligoarticular type JIA was higher in the boys (81 %) and
children aged 6–12 years (54 %), whereas that of polyar-
ticular type JIA was higher in the girls (56 %) and chil-
dren aged 13–16 years (Table 2). The mean (SD) age at
diagnosis of JIA was 11.3 (3.47) years. The prevalence of
all atopic diseases was significantly higher in the JIA
group than in the non-JIA group, including allergic con-
junctivitis (22.2 vs. 16.6 %), allergic rhinitis (31.9 vs.
23.9 %), asthma (13.1 vs. 9.5 %), and atopic dermatitis
(7.3 vs. 5.0 %), respectively (Table 3). The time interval
(years) between the diagnosis of specific allergic disease
and JIA was as follows: allergic conjunctivitis: mean =
3.86(SD = 2.30); allergic rhinitis: mean = 3.55(SD = 2.66);
asthma: mean = 4.52(SD = 2.65); atopic dermatitis:
mean = 3.09(SD = 2.47). In the whole study population,
an increased subsequent risk of JIA was observed in
the children with allergic conjunctivitis, allergic rhin-
itis, and asthma (Table 4). The adjusted odds ratios
(aOR) were 1.44 for allergic conjunctivitis (95 % confi-
dence interval [CI], 1.07–1.95), 1.50 for allergic rhinitis
(1.15–1.96), and 1.44 for asthma (1.00–2.10). When the
association was evaluated according to sex, the adjusted
risk increased to 1.70 for allergic rhinitis (95 % CI, 1.15–
2.50), 2.61 for atopic dermatitis (1.38–4.96) in girls
(Table 4). When the association was evaluated according
to age, the adjusted risk increased to 1.69 for allergic con-
junctivitis (95 % CI, 1.03–2.76), 1.97 for asthma (1.19–
3.25), and 1.95 for atopic dermatitis (1.05–3.62) in chil-
dren younger than 12 years (Table 4). When the allergic
patients were compared with those without any allergic
diseases, the adjusted OR of JIA increased with the num-
ber of allergic comorbidities. The aOR increased with the
number of allergic diseases, from 1.50 (95 % CI, 1.12–
2.01) for those with only one allergic disease to 1.72
Table 1 Annual incidence of juvenile idiopathic arthritis (JIA) in
Taiwan Children
Calendar year Total population JIA cases IR
2000 2951131 36 1.22
2001 2909223 31 1.07
2002 2853181 27 0.95
2003 2794477 32 1.15
2004 2743320 34 1.24
2005 2697539 48 1.78
2006 2638402 36 1.36
2007 2569563 45 1.75
2008 2499236 40 1.60
Total 24656072 329 1.33
IR Incidence rate, per 100,000
Table 2 Demographics and subtype of juvenile idiopathic
arthritis (JIA) in Taiwan Children between 2000 and 2008
Total Onset type of JIA
Oligoarticular Polyarticular Unspecified
n =329 n =33 n =263 n =33
n(%) n(%) n(%) n(%)
Sex
Male 161(49) 25(81) 117(44) 19(58)
Female 168(51) 8(19) 146(56) 14(42)
Age (year)
<2 0(0) 0(0) 0(0) 0(0)
2–5 20(6) 2(4) 15(6) 3(9)
6–12 142(43) 20(54) 108(41) 14(42)
13–16 167(51) 11(42) 140(53) 16(49)
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Table 3 Comparisons in socio-demographic factors and co-morbidities between cases with juvenile idiopathic arthritis (JIA) and
controls
Total n = 1645 non-JIA n = 1316 JIA n = 329
n % n % n % P-value
Age (year), mean ± SDa 11.3 ± 3.47 11.3 ± 3.47 11.3 ± 3.47 0.95
Stratified age 0.99
<12 645 (39.2) 516 (39.2) 129 (39.2)
≥12 1000 (60.8) 800 (60.8) 200 (60.8)
Sex 0.99
Girls 840 (51.1) 672 (51.1) 168 (51.1)
Boys 805 (48.9) 644 (48.9) 161 (48.9)
Urbanizationb 0.99
1 (highest) 495 (30.1) 396 (30.1) 99 (30.1)
2 490 (29.8) 392 (29.8) 98 (29.8)
3 270 (16.4) 216 (16.4) 54 (16.4)
4 (lowest) 390 (23.7) 312 (23.7) 78 (23.7)
Co-morbidity
Allergic conjunctivitis 0.02
No 1354 (82.3) 1098 (83.4) 256 (77.8)
Yes 291 (17.7) 218 (16.6) 73 (22.2)
Allergic rhinitis 0.003
No 1226 (74.5) 1002 (76.1) 224 (68.1)
Yes 419 (25.5) 314 (23.9) 105 (31.9)
Asthma 0.06
No 1477 (89.8) 1191 (90.5) 286 (86.9)
Yes 168 (10.2) 125 (9.50) 43 (13.1)
Atopic dermatitis 0.10
No 1555 (94.5) 1250 (95.0) 305 (92.7)
Yes 90 (5.47) 66 (5.02) 24 (7.29)
Chi-square test
at-test
bThe urbanization level was categorized by the population density of the residential area into 4 levels, with level 1 as the most urbanized and level 4 as the
least urbanized
Table 4 Association between allergic diseases and risk for juvenile idiopathic arthritis
All (N = 1645) Girls (N = 840) Boys (N = 805) Age < 12 (N = 645)a Age≥ 12 (N = 1000)a
Allergic diseases aOR (95 % CI) aOR (95 % CI) aOR (95 % CI) aOR (95 % CI) aOR (95 % CI)
AC 1.44 (1.07, 1.95)* 1.01 (0.63, 1.62) 1.92 (1.29, 2.87)** 1.69 (1.03, 2.76)* 1.33 (0.91, 1.96)
AR 1.50 (1.15, 1.96)** 1.70 (1.15, 2.50)** 1.36 (0.94, 1.97) 1.40 (0.93, 2.12) 1.59 (1.12, 2.26)**
Asthma 1.44 (1.00, 2.10)* 1.31 (0.74, 2.30) 1.57 (0.95, 2.58) 1.97 (1.19, 3.25)** 1.00 (0.56, 1.82)
AD 1.51 (0.93, 2.47) 2.61 (1.38, 4.96)** 0.74 (0.32, 1.71) 1.95 (1.05, 3.62)* 1.00 (0.43, 2.33)
Number of concurrent allergic disease
0 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (Reference) 1.00 (Reference)
1 1.50 (1.12, 2.01)** 1.69 (1.13, 2.53)* 1.34 (0.88, 2.05) 1.12 (0.61, 2.07) 1.29 (0.71, 2.35)
2+ 1.72 (1.24, 2.38)** 1.56 (0.95, 2.57) 1.84 (1.19, 2.86)** 1.42 (0.81, 2.50) 2.54 (1.42, 4.54)**
P for trend <0.001 0.02 0.006 0.002 0.04
Abbreviations: AC allergic conjunctivitis, AR allergic rhinitis, AD atopic dermatitis, OR odds ratio, CI 95 % confidence interval
aThe age is partitioned into two sub-segments (<12 vs. ≥12 years) based on mean age
*P < 0.05, **P < 0.01
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(1.24–2.38) for those with at least two allergic diseases (p
value for trend < 0.0001; Table 4) in a multivariate logistic
regression analysis. The adjusted ORs of JIA increased to
1.84 (95 % CI, 1.19–2.86) in boys and to 2.54 (1.42–4.54)
in children older than 12 year (Table 4). We further exam-
ined the association between the annual frequency of
medical visits due to allergic diseases and the risk of JIA,
and found that the aORs increased for allergic rhinitis
(2.27; 95 % CI, 1.42–3.63), asthma (2.05; 1.07–3.95), and
atopic dermatitis (3.89; 1.19–12.7), with two or more med-
ical visits per year (Table 5).
Discussion
Although the exact etiology of autoimmune diseases
such as JIA remains unknown, it is believed to develop
when a combination of genetic susceptibility and envir-
onmental encounters leads to the breakdown of toler-
ance [16–18]. Although methods for identifying JIA-
susceptibility genes have advanced [19], only few studies
have reported on the identification of environmental fac-
tors that trigger immunological aberrancies of JIA. Most
of these studies described the associations between
early-life infections, maternal smoking, and JIA [18–22].
Recently, three studies showed conflicting results on the
association between atopic disorders and rheumatoid
arthritis [23–26]. However, no reports have described
the influence of childhood-onset allergic diseases on the
risk of developing JIA. To the best of our knowledge,
this is the first report on the increased risk of JIA in chil-
dren with allergic diseases. The risk increased further
with the accumulation of evidence on concurrent aller-
gic diseases and the clinical burden of allergic diseases.
Although our results only showed that children with al-
lergic conjunctivitis, allergic rhinitis, or asthma were at
significantly increased risk of developing JIA, the pa-
tients with other allergic disorders revealed increased
frequency of JIA.
Epidemiological studies of JIA vary widely as regards
to study methodology, classification criteria, and popula-
tions [27]. Comparison of epidemiological studies of JIA
revealed that the annual incidence is 2.6 to 23 cases per
100,000 children per year and the estimated prevalence
was 15.7–140 cases per 100,000 children [28–34]. The
highest JIA incidence rates are found in some Scandi-
navian countries [30–32]. Studies from Asia revealed a
low prevalence of JIA [35, 36]. The prevalence of JIA
was estimated to be 3.8 cases per 100,000 children in
Taiwan in 1995–1999 [35]. According to a smaller study
from Japan, the annual incidence rate of JIA was esti-
mated to be 0.83 case per 100,000 children in 1997 [36].
In this study, the mean annual incidence of JIA was 1.33
cases per 100,000 children in 2000–2008. All the JIA
cases were obtained from the Registry for Catastrophic
Illness Patient Database (RCIPD), a subpart of the
NHIRD. In Taiwan, insured persons with major diseases
can apply for a catastrophic illness certificate that grants
exemption from copayment. The issuance of cata-
strophic illness certificates was validated by at least 2
specialists, based on careful examination of medical re-
cords, laboratory studies, and imaging studies. In
Taiwan, the agreed-upon criteria for diagnosis and classi-
fication of JIA were based on the ILAR revised classifica-
tion. Thus, the diagnostic accuracy for JIA should be
high. However, the underestimated incidence of JIA
based on data from the RCIPD should be considered be-
cause children with mild or oligoarticular disease may
not apply or be qualified for a catastrophic illness certifi-
cate [37]. Although the most common subtype in West-
ern European countries is represented by oligoarthritis,
this is rare in countries such as Costa Rica, India, New
Zealand, and South Africa, where polyarthritis predomi-
nates [27–30]. The present study revealed that the most
common subtype of JIA in Taiwan was the polyarticular
type. Previous studies from Asia showed that patients
with oligoarticular JIA were older at disease onset and
less likely to be female than their European counter-
parts, and that spondylarthropathy was more frequent in
Asian patients [29]. Our study demonstrated a similar
pattern that boys and children aged 6–12 years had
higher prevalence rates of oligoarticular JIA.
JIA describes a clinically heterogeneous group of arth-
ritis, which begins before 16 years of age. To date, the
cause of the disease is still poorly understood but seems
to be related to both genetic and environmental factors,
which result in the heterogeneity of the illness. Our re-
sults support childhood-onset allergic diseases as risk
factors of JIA. JIA is considered a complex genetic dis-
ease, and several genetic studies support that common
aberrant immune responses may cause both JIA and al-
lergic diseases. In Germany, Schubert et al. found an in-
verse association between several gene polymorphisms
involved in Th1- and Th2-driven inflammatory path-
ways, such as IL-4, CTLA4, and TNF-α, and asthma
and/or JIA [26]. In a Mexican population, Silvia et al.
Table 5 Association between frequency of annual medical visit
due to allergic disease and risk for juvenile idiopathic arthritisa
Frequency None ≤2 >2 P for
trendaOR (95 % CI) aOR (95 % CI) aOR (95 % CI)
Allergic diseases
AC 1.00 (Reference) 1.12 (0.74, 1.72) 1.52 (0.81, 2.89) 0.20
AR 1.00 (Reference) 1.41 (0.93, 2.12) 2.27 (1.42, 3.63)* <0.01
Asthma 1.00 (Reference) 1.45 (0.87, 2.39) 2.05 (1.07, 3.95)* <0.01
AD 1.00 (Reference) 1.42 (0.74, 2.73) 3.89 (1.19, 12.7)* 0.02
Abbreviations: AC allergic conjunctivitis, AR allergic rhinitis, AD atopic
dermatitis, aOR adjusted odds ratio, CI confidence interval
aEstimates from multiple logistic regression models adjusted for sex and age
*P < 0.001
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reported an association between the TNF alpha gene, a
common factor in the pathogenesis of pediatric inflam-
matory and/or autoimmune diseases such as asthma,
systemic lupus erythematosus, and JIA [32]. In Germany,
Heinzmann et al. reported that an IL13 (Th2 cytokine)
gene variant might prevent the development of JIA and
make an individual susceptible to atopic diseases [33]. In
addition to these genetic studies, common environmen-
tal triggers might be another explanation for the in-
creased risk of JIA in atopic children. Kokkonen et al.
found intestinal immune activation in most patients with
JIA and observed similar features in children with
delayed-type food hypersensitivity. This study implies
that food-borne antigens might initiate pathological cas-
cades in both disorders [34]. Recent evidence has sug-
gested the role or dysfunction of Treg cells in the
maintenance of immunological tolerance to environ-
mental triggers and the prevention of autoimmune dis-
eases and allergic diseases [31]. Treg cell dysfunction is
undoubtedly connected to the two disorders; this sup-
ports our findings.
This study is the first to precisely analyze the future
risk of JIA in children with common allergic diseases by
using a large population database with minimal selection
bias. However, it has some limitations. First, the diagno-
sis was based on the codes of the International Classifi-
cation of Diseases, Ninth Revision. Hence, detailed
clinical information such as anti-nuclear antibody titer,
rheumatoid factor titer, IgE level, specific IgE, severity of
arthritis and allergic symptoms, treatment response, sus-
ceptible genes, and environmental factors was lacking.
Second, because JIA is a rare disease, the difference in
related risk might be less significant or inconsistent de-
pending on the limited sample size in the age- or sex-
specific subpopulation analysis. Third, in this study, all
the JIA cases were obtained from the RCIPD. Although
the diagnostic accuracy for JIA should be high in the
present study, the underestimated incidence of JIA from
the RCIPD should be considered because children with
mild or oligoarticular disease may not apply or be quali-
fied for a catastrophic illness certificate [37]. In such
cases, selection bias might exist, as the undiagnosed
cases may be randomly selected as comparison controls.
Fourth, not all patients with atopic disease would neces-
sarily seek medical attention. These unrecognized and
uncounted patients who were not included in the dataset
will influence the results. Fifth, the subjects in this study
were Chinese; thus, the study results cannot be general-
ized to other populations.
Conclusions
In conclusion, children with onset of allergic diseases
were at increased risk of developing JIA, and the in-
creased risk was associated with the cumulative effect of
the clinical burden of allergic diseases. Further study to
investigate the role of Th2-mediated allergic diseases
that contribute to the development of Th1-mediated JIA
is warranted.
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